- Research works
- 21 ▲ 7% vs 2013–17
- Citations
- 581 27.9 per fractional work
- Top-10% rate
- 15.8% record average 16.5%
- Open access
- 47% world 28%
Not ranked overall: Shenzhen Chipscreen Biosciences Co. is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Shenzhen Chipscreen Biosciences Co.?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Transcriptional Regulation, Cancer Therapy, Metabolism, Cancer, Insulin Resistance, Diabetes and Obesity.
- Type 2 Diabetes
- endothelial progenitor cells
- PROTACs
- Thermogenesis
- Tumor Microenvironment
- PPARs
- Histone Deacetylases
- Gene Expression
- Obesity
- Insulin Resistance
- Metabolism
- Transcriptional Regulation
- Inflammation
- Cancer Therapy
- Cancer
- Diabetes
- Epigenetic Regulation
- HDAC Inhibitors
- Nuclear Receptors
- Peroxisome Proliferator-Activated Receptors
- Brown Adipose Tissue
- BET Bromodomains
- VEGF
- Herbal Medicine
- Bioactive Compounds
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 25 words, with their numbers
- Inflammation4▲ 8.9×10 topics
- Transcriptional Regulation3▲ 62×4 topics
- Cancer Therapy3▲ 24×7 topics
- Metabolism3▲ 21×8 topics
- Cancer3▲ 9.2×9 topics
- Insulin Resistance3▲ 28×5 topics
- Diabetes2▲ 24×3 topics
- Obesity2▲ 15×5 topics
- Epigenetic Regulation2▲ 51×4 topics
- Gene Expression2▲ 16×3 topics
- HDAC Inhibitors2▲ 498×1 topic
- Histone Deacetylases2▲ 498×1 topic
- Nuclear Receptors2▲ 51×2 topics
- PPARs2▲ 271×1 topic
- Peroxisome Proliferator-Activated Receptors2▲ 271×1 topic
- Tumor Microenvironment2▲ 21×5 topics
- Brown Adipose Tissue1▲ 86×1 topic
- Thermogenesis1▲ 86×1 topic
- BET Bromodomains1▲ 274×1 topic
- PROTACs1▲ 274×1 topic
- VEGF1▲ 162×1 topic
- endothelial progenitor cells1▲ 162×1 topic
- Herbal Medicine1▲ 23×2 topics
- Type 2 Diabetes1▲ 28×3 topics
- Bioactive Compounds1▲ 25×2 topics
Which research topics does Shenzhen Chipscreen Biosciences Co. publish most on?
By volume in 2022–2025: Thyroid Disorders and Treatments, Growth Hormone and Insulin-like Growth Factors, Liver Disease Diagnosis and Treatment and Peroxisome Proliferator-Activated Receptors.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Thyroid Disorders and Treatments Endocrinology, Diabetes and Metabolism 0 works
- 2 Growth Hormone and Insulin-like Growth Factors Endocrinology, Diabetes and Metabolism 0 works
- 3 Liver Disease Diagnosis and Treatment Epidemiology 0 works
- 4 Peroxisome Proliferator-Activated Receptors Molecular Biology 0 works
- 5 Histone Deacetylase Inhibitors Research Molecular Biology 0 works
- 6 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
- 7 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 0 works
- 8 Protein Degradation and Inhibitors Molecular Biology 0 works
- 9 Hematopoietic Stem Cell Transplantation Hematology 0 works
- 10 Dermatology and Skin Diseases Dermatology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Shenzhen Chipscreen Biosciences Co.'s research output changed?
Output in 2018–2022 was 7% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Shenzhen
- Ping An (China)
- Eighth Affiliated Hospital of Sun Yat-sen University
- Shenzhen MSU-BIT University
- BGI Genomics
- Shenzhen Urban Transport Planning Center Co.
- Shenzhen Ruipuxun Academy for Stem Cell & Regenerative Medicine
- GMT Technology (Shenzhen) Co., Ltd. (China)
- MGI
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.